EVOLENT HEALTH INC - A (EVH)
US30050B1017 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to EVH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 45.56. This target is 55.71% above the current price.
EVH was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about EVH.
In the previous month the buy percentage consensus was at a similar level.
EVH was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-22 | Citigroup | Initiate | Buy |
| 2024-03-28 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-15 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-01 | Oppenheimer | Initiate | Outperform |
| 2024-02-23 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-02-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-12-06 | JMP Securities | Initiate | Market Outperform |
| 2023-11-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-14 | Truist Securities | Maintains | Hold -> Hold |
| 2023-10-16 | UBS | Initiate | Buy |
| 2023-08-14 | Guggenheim | Reiterate | Buy -> Buy |
| 2023-06-26 | Guggenheim | Maintains | Buy -> Buy |
| 2023-05-24 | RBC Capital | Reiterate | Outperform |
| 2023-05-04 | Stephens & Co. | Reiterate | Overweight |
| 2023-04-12 | Stephens & Co. | Initiate | Overweight |
| 2023-02-23 | RBC Capital | Reiterate | Outperform |
| 2023-01-30 | Cowen & Co. | Maintains | Outperform |
| 2022-11-18 | Cowen & Co. | Maintains | Outperform |
| 2022-11-04 | Piper Sandler | Maintains | Overweight |
| 2022-11-01 | Truist Securities | Initiate | Hold |
| 2022-10-12 | BTIG | Maintains | Buy |
| 2022-10-12 | Canaccord Genuity | Maintains | Buy |
| 2022-08-19 | JP Morgan | Maintains | Overweight |
| 2022-08-03 | BTIG | Maintains | Buy |
| 2022-08-03 | RBC Capital | Maintains | Outperform |
| 2022-08-03 | Piper Sandler | Maintains | Overweight |
| 2022-07-29 | RBC Capital | Initiate | Outperform |
| 2022-06-21 | Cowen & Co. | Maintains | Outperform |
| 2022-05-09 | Canaccord Genuity | Maintains | Buy |
| 2021-11-18 | JP Morgan | Upgrade | Neutral -> Overweight |